Literature DB >> 30594065

Interleukin 27 polymorphisms, their association with insulin resistance and their contribution to subclinical atherosclerosis. The GEA Mexican study.

Gilberto Vargas-Alarcón1, Nonanzit Pérez-Hernández1, José Manuel Rodríguez-Pérez1, José Manuel Fragoso1, Carlos Posadas-Romero2, Fabiola López-Bautista1, Christian Vázquez-Vázquez1, Rosalinda Posadas-Sánchez3.   

Abstract

Our previous data suggest that the heterodimeric interleukin-27 (IL-27) could participate in the developing of insulin resistance (IR). Our aim was to assess the participation of IL-27p28 gene single nucleotide polymorphisms (SNPs) as markers for IR, subclinical atherosclerosis (SA) and cardiovascular risk factors in a Mexican population. Five IL-27p28 SNPs (rs153109, rs40837, rs17855750, rs26528 and rs181206) were genotyped in 856 individuals with IR and 644 participants without IR. Under inheritance models adjusted for confounding factors, the rs153109A (0.78[0.64-0.94] Padditive = 0.008, 0.58[0.41-0.82] Precessive = 0.002, 0.57[0.38-0.83] Pcodominant2 = 0.004), rs26528T (0.78[0.64-0.94] Padditive = 0.008, 0.61[0.43-0.88] Precessive = 0.007, 0.57[0.38-0.84] Pcodominant2 = 0.004) and rs40837A (0.76[0.63-0.92] Padditive = 0.004; 0.60[0.42-0.86] Precessive = 0.005; 0.54[0.37-0.80] Pcodominant2 = 0.002) alleles were related with a decreased risk of IR. Moreover, AAATA haplotype that contains the protector alleles was related with 17% lower risk of presenting IR (0.83 [0.71-0.98], P = 0.023). After adjusting for potential confounding variables, IL-27p28 SNPs were not associated with SA. However, some SNPs were associated with hypertension (rs26528 and rs40837) and increased total abdominal fat (rs17855750) in non-IR individuals, whereas in IR subjects we observed an association of rs26528 and rs40837 with hypoadiponectinemia. Our evidence suggests that rs40837A, rs153109A, and rs26528T alleles could be envisaged as protective markers for IR. Some polymorphisms showed an association with hypertension, low adiponectin levels, and increased total abdominal fat.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hypertension; Hypoadiponectinemia; Insulin resistance; Interleukin 27; Polymorphisms; Subclinical atherosclerosis

Mesh:

Substances:

Year:  2018        PMID: 30594065     DOI: 10.1016/j.cyto.2018.11.028

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  IL27 T4730C Polymorphism and Serology in Multiple Sclerosis: A Pilot Study.

Authors:  Ioana S Barac; Vitalie Văcăraș; Angela Cozma; Mădălina Văleanu; Nicoleta Decea; Dafin F Mureșanu; Lucia M Procopciuc
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.155

2.  Temporal response characterization across individual multiomics profiles of prediabetic and diabetic subjects.

Authors:  Minzhang Zheng; Carlo Piermarocchi; George I Mias
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

3.  The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection.

Authors:  Basant Mahmoud; Adel Abdel Moneim; Doaa Mabrouk
Journal:  Clin Exp Med       Date:  2021-11-10       Impact factor: 5.057

4.  Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level.

Authors:  Ioana S Barac; Mihaela Iancu; Vitalie Văcăraș; Angela Cozma; Vasile Negrean; Dorel Sâmpelean; Dafin F Mureșanu; Lucia M Procopciuc
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

Review 5.  Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges.

Authors:  Jing Ye; Yuan Wang; Zhen Wang; Ling Liu; Zicong Yang; Menglong Wang; Yao Xu; Di Ye; Jishou Zhang; Yingzhong Lin; Qingwei Ji; Jun Wan
Journal:  Front Pharmacol       Date:  2020-03-04       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.